Milk Thistle (Silymarin)

The VerdictLOW CONVICTION

Milk thistle nudges a liver blood test in people who already have liver disease, and does nothing for a healthy "detox."

Ask yourself one question. Has a doctor diagnosed you with a liver problem (like fatty liver) or put you on a medication that stresses the liver? If yes, milk thistle may modestly help a liver blood marker as an add-on. If no, you can skip it and save your money.

What the data actually shows: in people with diagnosed liver disease, milk thistle can lower a liver blood marker (ALT/AST), but the best biopsy trial, high dose for a year, did not reverse the actual liver damage.
The myth that won't die: "liver detox" for healthy people. There are no studies showing it helps a healthy liver, and the biggest hepatitis C trial found it did nothing to the virus.
Start here: if a doctor is managing your liver, look for "standardized silymarin" on the label (about 70-80%), roughly three standard capsules a day with food, not the cheap unlabelled seed powder.

Milk thistle is a seed extract that mops up damage inside liver cells and slows toxins from getting in. That's real chemistry, and it's exactly why an IV form is used in hospitals for poisonous-mushroom emergencies. But mopping up damage only helps when there's a fire. In a healthy liver there's nothing to put out, so there's nothing to gain.

That's the general answer. Your stack is different.

Check your whole stack

Ask yourself one question: has a doctor diagnosed you with a liver problem, or put you on a medication that stresses your liver?

If yes, milk thistle may modestly help a liver blood marker as an add-on under their care. If no, you can skip it and keep your money. There's no evidence it does anything for a healthy liver.

Takes 10 seconds. No equipment, no preparation.

The Protocol

Milk thistle is only worth a protocol if you're actually indicated for it. For a healthy person, the honest dose is none. These are the trial-tested ranges for the populations where there's a signal, and they belong under a clinician.

Who	Dose	Form	Timing
Healthy adult ("support/detox")	No effective dose, no use case	—	—
Diagnosed fatty liver (NAFLD/MASLD), clinician-led	~140 mg standardized silymarin, 3× daily (~420 mg/day, about three standard capsules)	Standardized silymarin (Legalon-type) or silybin-phosphatidylcholine	With meals
On anti-tuberculosis drugs, clinician-led	~420 mg/day	Standardized silymarin	With the regimen
Thalassemia iron overload (adjunct), clinician-led	~140 mg 3× daily plus chelator	Silymarin	With chelation

Note: the year-long biopsy trial pushed the dose all the way to 2100 mg/day to overcome poor absorption, and still missed its main tissue endpoint. More milligrams did not buy a better outcome.

Which form

Standardized silymarin

Legalon-type, 70-80%

The form behind the positive trials. The percentage matters, not the total mg.

Silybin-phosphatidylcholine

Siliphos / IdB1016

Absorbs better than plain silymarin. Costs more.

Generic "milk thistle seed"

undisclosed content

Often not what was studied. You don't know what's inside.

Absorption tip: silymarin is poorly absorbed, so the form is the whole game. Take it with food, and buy on the stated "standardized silymarin %" (around 70-80%). Ignore the big "1000 mg milk thistle" number on the front of the bottle. If a product doesn't disclose silymarin content, you don't actually know what you're paying for.

Safety & Interactions

This is the genuinely good news about milk thistle: it's well tolerated, and its interaction risk is lower than its herbal reputation suggests. The realistic downside is wasted money, not harm.

Most medications — reassuringly low risk

In human studies, milk thistle did not meaningfully change levels of test drugs (like indinavir) and had minimal effect on the liver enzymes that process most medications at normal doses.

Blood thinners / certain statins at high doses

A theoretical mild interaction at high silymarin doses, not confirmed in real-world use. If you're on a blood thinner and want high doses, clear it with your doctor first.

Daisy / ragweed (Asteraceae) allergy

Milk thistle is in the daisy family. If you react to ragweed, daisies, or marigolds, you could react to this too. Avoid it.

Who should avoid it

Anyone allergic to the daisy/ragweed family — cross-reaction risk.
Pregnant or breastfeeding women — not enough safety data, despite one small "more milk supply" study. Not a green light.
People on narrow-margin blood thinners at high doses without medical oversight.

Upper limit

No formal upper limit has been set. Trials have run 2100 mg/day of standardized silymarin for 48 weeks without serious side effects, which is a tested ceiling, not a safety threshold. Side effects, when they happen, are mild: loose stools, mild stomach upset, bloating.

Conviction: LOW-to-MODERATE

Moderate that it lowers a liver blood marker in people with diagnosed liver disease. Low that it reverses actual liver damage. Debunked for hepatitis C and for any healthy-person "detox." The strongest, best-evidenced part of the milk thistle story is what it does not do.

What would change this verdict?

An independent (not industry-funded) trial of at least 200 people with biopsy-confirmed fatty liver disease, using a well-absorbed silibinin formulation for at least a year, that actually improves liver tissue (not just a blood marker) on the main analysis. That would move liver-disease conviction up. For "healthy liver support" to move off zero, any solid trial in healthy people showing a real benefit would be needed. None exists.

Worth Your Money?

Weekly costRoughly £1.50–£3 per week for a standardized product (about three capsules a day).

Worth it ifA doctor is managing your diagnosed liver disease and wants an add-on that may nudge a liver blood marker.

Lower priority ifYou're healthy. There's no benefit to buy. Your next £10 goes much further on losing weight, cutting alcohol, and nailing the basics — those actually move liver health.

Skip (for healthy buyers)

Go Deeper

Want to stop wasting money on supplements that don't do what the label says? The Verdict reviews one every week, free.

Get the free weekly review

Claims vs Evidence — See What the Research Found

What People Claim

"Milk thistle detoxes, cleanses, and protects your liver. Anyone who drinks, takes medication, or eats poorly should be on it as insurance."

That's the pitch, and it's why milk thistle is one of the best-selling herbal supplements in the world. There's a kernel of truth underneath it. The plant has been used for liver complaints for centuries, the active compounds genuinely have antioxidant activity, and there's a real hospital use: an intravenous form treats death-cap mushroom poisoning. The marketing borrows the credibility of that real use and stretches it across a much bigger set of claims.

What the Evidence Actually Shows

Claim	Verdict	What the data says
Lowers liver enzymes in fatty liver	MODERATE	Consistent blood-marker drop across meta-analyses (Zhong 2017, de Avelar 2017). Heterogeneous.
Reverses fatty-liver tissue damage	LOW	Best biopsy RCT missed its primary endpoint at 2100 mg/day for a year (Wah Kheong 2017).
Prevents drug-induced liver injury (anti-TB)	MODERATE	Meta-analysis shows reduced injury in this at-risk group (Zhong 2019).
Improves blood sugar / insulin resistance	LOW-MOD	Improved insulin marker, a surrogate not a hard outcome (Hashemi-Tabandeh 2025).
Treats hepatitis C (oral)	DEBUNKED	Biggest oral trial found no effect on enzymes or virus (SyNCH, Fried 2012; Yang 2014).
"Detox / cleanse" a healthy liver	NONE	No trials. There is no evidence of benefit in healthy people.
Stops compulsive hair-pulling (trichotillomania)	DEBUNKED	Placebo-controlled trial was explicitly negative (Grant 2019).

The Full Picture — Mechanism, Debate & Nuance

How It Works

Silymarin isn't one molecule. It's a cluster of compounds from milk thistle seeds, and the main active one is silibinin. Its liver protection rests on three actions, all real at the lab level. It mops up reactive molecules and reduces oxidative damage. It calms inflammation signalling, which maps onto the lower enzyme leakage seen in trials. And it physically blocks a transporter that toxins use to enter liver cells, which is the genuine basis for the intravenous form used against death-cap poisoning.

Here's the honest part. These mechanisms explain why a blood marker moves. They don't prove the liver is structurally better off. A liver enzyme falling tells you fewer cells are leaking this week. It doesn't tell you the disease reversed. And there's a catch that undercuts the whole thing in practice: silymarin is poorly absorbed and rapidly cleared, so the dose on the label and the dose reaching your liver are very different numbers.

The Debate

Blood marker vs actual tissue

Liver-disease meta-analyses

Silymarin significantly lowers ALT and AST.

Wah Kheong 2017 (NASH biopsy RCT)

Primary tissue endpoint not met, even at 2100 mg/day for a year.

The blood marker moves. The tissue outcome doesn't reliably follow. That gap is the whole milk thistle story.

Does it do anything for hepatitis C?

Early/observational claims

Milk thistle "supports" the liver in viral hepatitis.

SyNCH RCT (Fried 2012, JAMA)

No effect on liver enzymes or viral load at high oral doses.

The best independent oral trial found nothing antiviral. That claim is effectively settled.

Honest Limitations

Formulation roulette

Trials used standardized silymarin or better-absorbed complexes. The shelf is full of unstandardized "seed" capsules. Real-world results are likely weaker than trials, because people often aren't taking the studied substance.

Wrong population

Every positive signal is in people who already have liver disease or a toxic exposure. The typical buyer is a healthy person seeking insurance. For them, the expected benefit is zero, not "small."

A marker, not an outcome

The win is a blood-test number. People expect to feel "detoxed" or to repair damage. The data doesn't deliver the felt or structural benefit being sold.

The Nuance

The one genuinely established medical use of milk thistle is intravenous silibinin for death-cap mushroom poisoning. That's a hospital drug given by drip, not a capsule you buy. It does not transfer to "take a pill to protect your liver."

What doesn't work

"Liver detox / cleanse" for healthy people — no trials show benefit; "detox" is a marketing word, not a medical one.
Milk thistle for hepatitis C (oral) — the SyNCH trial and a meta-analysis found no antiviral effect.
Reversing fatty-liver damage — the best biopsy trial missed its main endpoint even at a high dose.
Undoing alcohol damage / curing cirrhosis — an early survival signal was never reliably repeated.

Food-first note: there's no food alternative, because milk thistle isn't a nutrient your body needs. The best first money for liver health goes to weight loss, less alcohol, and treating the underlying metabolic driver.

Sources

Zhong S, et al. (2017). Silymarin in NAFLD: meta-analysis (PRISMA) of RCTs. Medicine. Liver enzyme reduction.
de Avelar CR, et al. (2017). Silymarin on biochemical indicators in liver disease: systematic review with meta-analysis. World J Gastroenterol. AST/ALT reduced, high heterogeneity.
Wah Kheong C, et al. (2017). Randomized trial of silymarin for NASH. Clin Gastroenterol Hepatol. N=99; primary histological endpoint not met.
Zhong S, et al. (2019). Silymarin prophylaxis for anti-tuberculosis drug-induced liver injury: meta-analysis. Can J Gastroenterol Hepatol. Reduced injury incidence.
Yang Z, et al. (2014). Silymarin in chronic hepatitis C: meta-analysis of RCTs. BioMed Res Int. No virologic effect.
Fried MW, et al. (2012). Silymarin in chronic hepatitis C (SyNCH RCT). JAMA. Null on ALT and HCV RNA.
Hashemi-Tabandeh, et al. (2025). Silymarin on insulin resistance: meta-analysis. Diabetes Res Clin Pract. Improved insulin marker.
Grant JE, et al. (2019). Milk thistle for trichotillomania: placebo-controlled crossover, negative. J Clin Psychopharmacol.
Saller R, et al. (2008). Updated systematic review with meta-analysis of silymarin. Forsch Komplementmed. Survival benefit not robust.